Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia
Objective: Mice with congenital loss of the glucagon receptor gene (Gcgr−/− mice) remain normoglycemic in insulinopenic conditions, suggesting that unopposed glucagon action is the driving force for hyperglycemia in Type-1 Diabetes Mellitus (T1DM). However, chronic loss of GCGR results in a neomorph...
Saved in:
Main Authors: | Belen Rivero-Gutierrez (Author), April Haller (Author), Jenna Holland (Author), Emily Yates (Author), Radha Khrisna (Author), Kirk Habegger (Author), Richard Dimarchi (Author), David D'Alessio (Author), Diego Perez-Tilve (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Glucagon-like peptide 1 (GLP-1)
by: T.D. Müller, et al.
Published: (2019) -
5-HT2A deletion protects against Clozapine-induced hyperglycemia
by: Radhika Sudhir Joshi, et al.
Published: (2019) -
Liraglutide Activates Glucagon-Like Peptide 1 Receptor to Attenuate Hyperglycemia through Endogenous Beta-Endorphin in Diabetic Rats
by: Kai-Chun Cheng, et al.
Published: (2020) -
Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice
by: Patrick J. Knerr, et al.
Published: (2022) -
Glucagon receptor gene deletion in insulin knockout mice modestly reduces blood glucose and ketones but does not promote survival
by: Ursula H. Neumann, et al.
Published: (2016)